KLRK1 and neoplasm: Methylselenol, a metabolite of selenium, upregulates natural killer group 2 member D (NKG2D) ligands on the surface of the tumor cells which are then recognized and eliminated by the CD8+ T cells also expressing NKG2D (Hagemann-Jensen et al., 2014).